Á lódáil...
Clinical Research Progress of Immune Checkpoint Inhibitors in the Treatment of Small Cell Lung Cancer
With the in-depth study of tumor immunity, immunotherapy represented by immune checkpoint inhibitors has made a great breakthrough in solid tumors. Small cell lung cancer (SCLC) accounts for about 15%-20% of all lung cancers, with high malignancy, early metastasis and lack of effective treatment str...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formáid: | Artigo |
| Teanga: | Chinês |
| Foilsithe: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2019-04-01
|
| Sraith: | Chinese Journal of Lung Cancer |
| Ábhair: | |
| Rochtain Ar Líne: | http://dx.doi.org/10.3779/j.issn.1009-3419.2019.04.07 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|